SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Investview, Inc. (INVU) .
Criteria proven by this page:
- VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.
Overall SharesGrow Score: 30/100 with 0/7 criteria passed.
SharesGrow 7-Criteria Score
~
HEALTH
67/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — INVU
Valuation Multiples
P/E (TTM)0.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio1.33
EV/EBITDA0.0
Per Share Data
EPS (TTM)$-0.01
Book Value / Share$0.00
Revenue / Share$0.02
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2013 |
$-0.69 |
$1.05M |
$-4.15M |
-396.1% |
| 2014 |
$-0.78 |
$709.23K |
$-9.17M |
-1292.3% |
| 2015 |
$-0.14 |
$353.93K |
$-2.1M |
-594.6% |
| 2016 |
$0.05 |
$131.47K |
$1.75M |
1333.9% |
| 2017 |
$-0.01 |
$17.92M |
$-14.91M |
-83.2% |
| 2019 |
$0.00 |
$29.66M |
$-4.98M |
-16.8% |
| 2020 |
$-0.01 |
$24.18M |
$-21.29M |
-88% |
| 2022 |
$0.00 |
$61.85M |
$-12.94M |
-20.9% |
| 2024 |
$0.00 |
$52.38M |
$1.19M |
2.3% |
| 2025 |
$-0.01 |
$36.26M |
$-8.91M |
-24.6% |
